Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non‐critical COVID‐19 pneumonia: A double‐blind randomized, placebo‐controlled clinical trial

INTRODUCTION: Selective serotonin reuptake inhibitors are considered the drugs, whose effectiveness in viral pandemics has been studied. The aim of this study was to evaluate of adding fluoxetine to the treatment regimen of patients with COVID‐19 pneumonia. METHODS: This study was a double‐blind ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Sedighi, Faranak, Zarghami, Mehran, Alizadeh Arimi, Fatemeh, Moosazadeh, Mahmood, Ala, Shahram, Ghasemian, Roya, Mehravaran, Hossein, Elyasi, Forouzan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275279/
https://www.ncbi.nlm.nih.gov/pubmed/36941089
http://dx.doi.org/10.1002/npr2.12327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275279/
https://www.ncbi.nlm.nih.gov/pubmed/36941089
http://dx.doi.org/10.1002/npr2.12327

Ejemplares similares